These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 30931926)

  • 1. NRG1 type I dependent autoparacrine stimulation of Schwann cells in onion bulbs of peripheral neuropathies.
    Fledrich R; Akkermann D; Schütza V; Abdelaal TA; Hermes D; Schäffner E; Soto-Bernardini MC; Götze T; Klink A; Kusch K; Krueger M; Kungl T; Frydrychowicz C; Möbius W; Brück W; Mueller WC; Bechmann I; Sereda MW; Schwab MH; Nave KA; Stassart RM
    Nat Commun; 2019 Apr; 10(1):1467. PubMed ID: 30931926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble Neuregulin1 is strongly up-regulated in the rat model of Charcot-Marie-Tooth 1A disease.
    Fornasari BE; Ronchi G; Pascal D; Visigalli D; Capodivento G; Nobbio L; Perroteau I; Schenone A; Geuna S; Gambarotta G
    Exp Biol Med (Maywood); 2018 Feb; 243(4):370-374. PubMed ID: 29350067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low affinity NGF receptor expression in CMT1A nerve biopsies of different disease stages.
    Hanemann CO; Gabreëls-Fasten AA; Müller HW; Stoll G
    Brain; 1996 Oct; 119 ( Pt 5)():1461-9. PubMed ID: 8931571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schwann cell differentiation in Charcot-Marie-Tooth disease type 1A (CMT1A): normal number of myelinating Schwann cells in young CMT1A patients and neural cell adhesion molecule expression in onion bulbs.
    Hanemann CO; Gabreëls-Festen AA; Stoll G; Müller HW
    Acta Neuropathol; 1997 Oct; 94(4):310-5. PubMed ID: 9341930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for Schwann cell-derived neuregulin-1 in remyelination.
    Stassart RM; Fledrich R; Velanac V; Brinkmann BG; Schwab MH; Meijer D; Sereda MW; Nave KA
    Nat Neurosci; 2013 Jan; 16(1):48-54. PubMed ID: 23222914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The alpha-chemokine CXCL14 is up-regulated in the sciatic nerve of a mouse model of Charcot-Marie-Tooth disease type 1A and alters myelin gene expression in cultured Schwann cells.
    Barbaria EM; Kohl B; Buhren BA; Hasenpusch-Theil K; Kruse F; Küry P; Martini R; Müller HW
    Neurobiol Dis; 2009 Mar; 33(3):448-58. PubMed ID: 19111616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced axonal neuregulin-1 type-III signaling ameliorates neurophysiology and hypomyelination in a Charcot-Marie-Tooth type 1B mouse model.
    Scapin C; Ferri C; Pettinato E; Zambroni D; Bianchi F; Del Carro U; Belin S; Caruso D; Mitro N; Pellegatta M; Taveggia C; Schwab MH; Nave KA; Feltri ML; Wrabetz L; D'Antonio M
    Hum Mol Genet; 2019 Mar; 28(6):992-1006. PubMed ID: 30481294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferation of Schwann cells and regulation of cyclin D1 expression in an animal model of Charcot-Marie-Tooth disease type 1A.
    Atanasoski S; Scherer SS; Nave KA; Suter U
    J Neurosci Res; 2002 Feb; 67(4):443-9. PubMed ID: 11835311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imbalance of NRG1-ERBB2/3 signalling underlies altered myelination in Charcot-Marie-Tooth disease 4H.
    El-Bazzal L; Ghata A; Estève C; Gadacha J; Quintana P; Castro C; Roeckel-Trévisiol N; Lembo F; Lenfant N; Mégarbané A; Borg JP; Lévy N; Bartoli M; Poitelon Y; Roubertoux PL; Delague V; Bernard-Marissal N
    Brain; 2023 May; 146(5):1844-1858. PubMed ID: 36314052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral myelin protein-22 expression in Charcot-Marie-Tooth disease type 1a sural nerve biopsies.
    Hanemann CO; Stoll G; D'Urso D; Fricke W; Martin JJ; Van Broeckhoven C; Mancardi GL; Bartke I; Müller HW
    J Neurosci Res; 1994 Apr; 37(5):654-9. PubMed ID: 8028042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerability and efficacy study of P2X7 inhibition in experimental Charcot-Marie-Tooth type 1A (CMT1A) neuropathy.
    Sociali G; Visigalli D; Prukop T; Cervellini I; Mannino E; Venturi C; Bruzzone S; Sereda MW; Schenone A
    Neurobiol Dis; 2016 Nov; 95():145-57. PubMed ID: 27431093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuregulin 1-erbB signaling is necessary for normal myelination and sensory function.
    Chen S; Velardez MO; Warot X; Yu ZX; Miller SJ; Cros D; Corfas G
    J Neurosci; 2006 Mar; 26(12):3079-86. PubMed ID: 16554459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-Jun activation in Schwann cells protects against loss of sensory axons in inherited neuropathy.
    Hantke J; Carty L; Wagstaff LJ; Turmaine M; Wilton DK; Quintes S; Koltzenburg M; Baas F; Mirsky R; Jessen KR
    Brain; 2014 Nov; 137(Pt 11):2922-37. PubMed ID: 25216747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impairment of PMP22 transgenic Schwann cells differentiation in culture: implications for Charcot-Marie-Tooth type 1A disease.
    Nobbio L; Vigo T; Abbruzzese M; Levi G; Brancolini C; Mantero S; Grandis M; Benedetti L; Mancardi G; Schenone A
    Neurobiol Dis; 2004 Jun; 16(1):263-73. PubMed ID: 15207283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuregulin 1 type III improves peripheral nerve myelination in a mouse model of congenital hypomyelinating neuropathy.
    Belin S; Ornaghi F; Shackleford G; Wang J; Scapin C; Lopez-Anido C; Silvestri N; Robertson N; Williamson C; Ishii A; Taveggia C; Svaren J; Bansal R; Schwab MH; Nave K; Fratta P; D'Antonio M; Poitelon Y; Feltri ML; Wrabetz L
    Hum Mol Genet; 2019 Apr; 28(8):1260-1273. PubMed ID: 30535360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myelin is dependent on the Charcot-Marie-Tooth Type 4H disease culprit protein FRABIN/FGD4 in Schwann cells.
    Horn M; Baumann R; Pereira JA; Sidiropoulos PN; Somandin C; Welzl H; Stendel C; Lühmann T; Wessig C; Toyka KV; Relvas JB; Senderek J; Suter U
    Brain; 2012 Dec; 135(Pt 12):3567-83. PubMed ID: 23171661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of ErbB2 and ErbB3 receptors in Schwann cells of patients with Charcot-Marie-tooth disease type 1A.
    Massa R; Palumbo C; Cavallaro T; Panico MB; Bei R; Terracciano C; Rizzuto N; Bernardi G; Modesti A
    Muscle Nerve; 2006 Mar; 33(3):342-9. PubMed ID: 16307437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A transgenic rat model of Charcot-Marie-Tooth disease.
    Sereda M; Griffiths I; Pühlhofer A; Stewart H; Rossner MJ; Zimmerman F; Magyar JP; Schneider A; Hund E; Meinck HM; Suter U; Nave KA
    Neuron; 1996 May; 16(5):1049-60. PubMed ID: 8630243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the colony stimulating factor 1 receptor alleviates two forms of Charcot-Marie-Tooth disease in mice.
    Klein D; Patzkó Á; Schreiber D; van Hauwermeiren A; Baier M; Groh J; West BL; Martini R
    Brain; 2015 Nov; 138(Pt 11):3193-205. PubMed ID: 26297559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oct6, a transcription factor controlling myelination, is a marker for active nerve regeneration in peripheral neuropathies.
    Kawasaki T; Oka N; Tachibana H; Akiguchi I; Shibasaki H
    Acta Neuropathol; 2003 Mar; 105(3):203-8. PubMed ID: 12557005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.